A brief overview of targeted radionuclide therapy trials in 2022

There is a growing use of radionuclide therapy for the medical care oncology patients, where radioactive pharmaceuticals are used to target and treat various cancer types. This paper provides brief overview illustrating spectrum ongoing recently completed clinical trials in oncology. The selected highlight potential therapies provide promising treatment option across while also discussing importance patient selection monitoring, as well side effects safety concerns. Ultimately, results these will be crucial determining future treatment.